Brequinar Sodium

布喹那钠

Report date: 2026/04/28 20:00:22
NME

Base Information

Drug NameBrequinar Sodium
Drug Alias NameBipenquinate布喹那NSC-368390DUP-785NSC-369390
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDihydroorotate dehydrogenase inhibitors
TargetsDihydroorotate dehydrogenase
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Leukemia, Myeloid, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesIndia
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBristol-Myers Squibb Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesClear Creek Bio Inc
Active IndicationsN/A
Inactive IndicationsCoronavirus Disease 2019 (COVID-19)Leukemia, Myeloid, Acute

Other Information

ATC CodeN/A
Related LinksN/A